Featured Research

from universities, journals, and other organizations

New Training Method Helps Surgeons Evaluate Their Own Minimally Invasive Surgery Skills

Date:
January 12, 2009
Source:
Delft University of Technology
Summary:
Recent years have seen the rapid emergence of minimally invasive surgery procedures in operating theatres. However, the training of surgeons in this field still leaves much to be desired. Researchers have now changed this state of affairs by developing a realistic training system which records and analyses the surgeon's movements. As a result there is now, for the first time, an objective benchmark for measuring a surgeon's basic skills in the field of minimally invasive surgery.

Recent years have seen the rapid emergence of minimally invasive surgery procedures in operating theatres. However, the training of surgeons in this field still leaves much to be desired.

Researcher Magdalena Chmarra has changed this state of affairs by developing a realistic training system which records and analyses the surgeon's movements. As a result there is now, for the first time, an objective benchmark for measuring a surgeon's basic skills in the field of minimally invasive surgery.

Chmarra will receive her PhD for this research at Delft University of Technology in The Netherlands on Monday 12 January.

Recent years have seen the rapid emergence of minimally invasive surgery procedures in operating theatres. Despite its considerable advantages, this relatively recent surgical technique still has a number of drawbacks. One such disadvantage relates to the training of surgeons, which is still, for the most part, delivered in a rather unstructured manner and, moreover, without any objective benchmark with which to measure the progress made by trainee surgeons.

Training

Broadly speaking, there are currently two safe training methods for minimally invasive surgery. The first is the so-called box trainer, an enclosed rectangular box in which trainee surgeons can practise performing basic manipulative tasks with the surgical devices, such as picking up and moving objects. As they do this, they can be assessed by an experienced surgeon. Clearly, this is a somewhat subjective process.

The other option is the virtual reality trainer, employing computer simulations, which allows for excellent recording and analysis of the surgeon's actions. However, this training method still has the major disadvantage that it lacks realism. For example, users feel no tactile response when performing surgical tasks.

TrEndo

Thus both of these training methods have their drawbacks. The Delft doctoral candidate Magdalena Chmarra has sought to change this situation by developing a training tool that is realistic for the surgeon and at the same time records and analyses the motion of the instruments manipulated by the surgeon. This is accomplished with an inexpensive and relatively simple tracking device known as the ‘TrEndo’. A TrEndo incorporates three optical computer-mouse sensors which record the movements made by the surgeon in all directions.

The TrEndo has been extensively tested by medical staff at Leiden University Medical Centre, who rate the device highly. The movements that they performed with the TrEndo felt no different from those undertaken with the actual surgical devices.

TrEndo is currently undergoing further fine-tuning at Delft University of Technology.

Benchmarking

The TrEndo helps to identify the key factors underlying the basic skills required by surgeons, thus paving the way for objective benchmarking of their competence in the field of minimally invasive surgery. By means of motion analysis, Chmarra has therefore succeeded in arranging the basic skills of the participating trainee surgeons into a classification system which ranks them as being either expert, intermediate or beginner.


Story Source:

The above story is based on materials provided by Delft University of Technology. Note: Materials may be edited for content and length.


Cite This Page:

Delft University of Technology. "New Training Method Helps Surgeons Evaluate Their Own Minimally Invasive Surgery Skills." ScienceDaily. ScienceDaily, 12 January 2009. <www.sciencedaily.com/releases/2009/01/090112093505.htm>.
Delft University of Technology. (2009, January 12). New Training Method Helps Surgeons Evaluate Their Own Minimally Invasive Surgery Skills. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/01/090112093505.htm
Delft University of Technology. "New Training Method Helps Surgeons Evaluate Their Own Minimally Invasive Surgery Skills." ScienceDaily. www.sciencedaily.com/releases/2009/01/090112093505.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins